Varenicline for treatment of e-cigarette dependence
Conditions
Addictive Behaviors | Tobacco Addiction
Phase Pilot
Volunteers
Health Professionals
What is the purpose of this trial?
This study aims to understand if varenicline can help people who regularly use e-cigarettes stop or reduce vaping. Participants will receive an 8-week supply of either varenicline or a matching placebo and answer weekly questionnaires. The study is fully remote and involvement lasts 12-weeks. Compensation of up to $185 is provided.
Link to go directly to the prescreener here: https://redcap.musc.edu/surveys/?s=8HWXTWHK3WPDHA4T
Study Coordinators:
- Ali Serrantino; 203-464-7850; alison.serrantino@yale.edu
- Rebecca Marrero; 203-464-7135; rebecca.marrero@yale.edu
- Lab email: tobaccostudy@yale.edu
- Ages18 years and older
- GenderBoth
- Trial withYale University School of Medicine
- Start Date06/10/2022
- End Date12/31/2023
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Last Updated12/22/2022
- Study HIC#2000032740